The biomechanics held up and the market never rewarded them. What survives, who still sells it, and why nobody has launched a new one in fifteen years. There is a simple test for whether a spine category is finished, and it is not the sales line. It is whether anyone is still spending money on it. New platforms, new clearances, new trials. By … [Read More...] about Whatever Happened to the Translational Cervical Plates? Twelve Are Still Out There | Update 2026
Main Content
BREAKING NEWS
Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance
GALWAY, Ireland, Sept. 1, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2027 (FY27), which ended July 31, 2026. Key Highlights "We are off to a strong start in fiscal 2027. What gives us confidence is not simply the strength of the quarter, but importantly, the breadth of … [Read More...] about Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance
eCential Robotics Announces Binding Offer from Enovis
GRENOBLE, France and FRANKLIN, Tenn., Sept. 1, 2026 /PRNewswire/ -- eCential Robotics, a leading developer of enabling technologies and surgical robotics, today announced that Enovis™ Corporation (NYSE: ENOV) has entered a binding offer to acquire the company. Following completion of the information and consultation process with eCential Robotics' works council in accordance with … [Read More...] about eCential Robotics Announces Binding Offer from Enovis
Spine Augmentation Market Forecast: Growth Doesn’t Come From Fractures. It Comes From Evidence.
The market is projected at $3.08 billion by 2030. The two procedures inside that number have not behaved the same way at all. The Business Research Company has a new forecast out. Spine augmentation systems: $2.14 billion this year, $2.31 billion next, $3.08 billion by 2030. That works out at 7.6% a year. The drivers are the familiar ones. Aging populations. Osteoporosis. Minimally invasive … [Read More...] about Spine Augmentation Market Forecast: Growth Doesn’t Come From Fractures. It Comes From Evidence.
Kyrgyzstan Signs With Turkey’s Mikron. Fewer Middlemen, Lower Prices — What About Service?
Kyrgyzfarmatsiya, the Kyrgyz state pharmaceutical enterprise, has signed a memorandum of understanding with Turkey's Mikron Medical to supply orthopedic and spinal implants to hospitals in the country.The reason given is the interesting bit. Kyrgyzfarmatsiya says buying straight from manufacturers should cut the number of intermediaries and bring costs down. If you sell implants into state tenders … [Read More...] about Kyrgyzstan Signs With Turkey’s Mikron. Fewer Middlemen, Lower Prices — What About Service?
Regenxbio Looked. That Was the Problem.
Five asymptomatic spinal findings, a halted gene therapy, and a warning for anyone putting biologics into the spinal canal Regenxbio said on August 24 that the FDA had put RGX-121 back on clinical hold. The trigger was five MRI scans showing small nodules or cystic masses in patients' spines. None of those patients had symptoms. All five are doing fine. Those scans only exist because of an … [Read More...] about Regenxbio Looked. That Was the Problem.
Spineart and eCential Robotics receive FDA 510(k) clearance for the PERLA® TL application for use with eCential® Op.n® navigation system for robotic procedures.
GENEVA, Aug. 26, 2026 /PRNewswire/ -- Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the PERLA® TL application (PERLA® by Spineart app) for use with the eCential® Op.n® Navigation and Robotic-Assisted Platform. Building on the previously … [Read More...] about Spineart and eCential Robotics receive FDA 510(k) clearance for the PERLA® TL application for use with eCential® Op.n® navigation system for robotic procedures.
What Globus Medical Really Bought With Higgs Boson Health
Higgs Boson Health is a seed-stage company with a patient-facing product. The question worth asking is why a company guiding to $3.2 billion this year needed one. Globus Medical announced on August 26 that it has acquired Higgs Boson Health, a digital healthcare experience company based in Durham, North Carolina and incubated out of Duke University. No price was disclosed, and there is a reason … [Read More...] about What Globus Medical Really Bought With Higgs Boson Health
Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions
AUDUBON, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the acquisition of Higgs Boson Health, a digital healthcare experience company based in Durham, NC and incubated out of Duke University. With a mission to transform healthcare experience through digital innovation, … [Read More...] about Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions
Amplio Spine™ Appoints Nomen Azeem, MD, as Chief Clinical Officer and Founding Chair of the Clinical Advisory Board
BOCA RATON, Fla., Aug. 25, 2026 /PRNewswire/ -- Amplio Spine announced today that Nomen Azeem, MD, FAAPMR has joined the company as Chief Clinical Officer and Founding Chair of the Advisory Board. Dr. Azeem brings 15 years of clinical leadership in interventional spine and pain medicine, with experience in research oversight, clinical strategy, and surgical … [Read More...] about Amplio Spine™ Appoints Nomen Azeem, MD, as Chief Clinical Officer and Founding Chair of the Clinical Advisory Board
DeGen Medical Issues Statement on New CMS FY2027 Inpatient Classification for Patient-Specific Lumbar Fusion Procedures
Florence, SC, Aug. 25, 2026 (GLOBE NEWSWIRE) -- DeGen Medical, Inc., a U.S.-based medical device manufacturer specializing in patient-specific spinal implants, today issued a statement regarding the new FY2027 Centers for Medicare & Medicaid Services (CMS) inpatient classification for custom-made, anatomically and virtually designed interbody fusion devices and what the change means for … [Read More...] about DeGen Medical Issues Statement on New CMS FY2027 Inpatient Classification for Patient-Specific Lumbar Fusion Procedures
SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory
PARIS, August 24, 2026 – 6:00 p.m. CEST - SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and … [Read More...] about SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory